Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the SynFlow 3.0 Percutaneous Transvalvular Ventricular Assist System in Patients Undergoing High-Risk PCI: A Prospective, Multicenter, Randomized Controlled, Non-inferiority Trial (PERSIST Ⅲ Study)

NCT06853470 is registered in ClinicalTrials.gov with ForQaly Medical (Shanghai) Co., Ltd as lead sponsor.

NCT NCT06853470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06853470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the SynFlow 3.0 Percutaneous Transvalvular Ventricular Assist System in Patients Undergoing High-Risk PCI: A Prospective, Multicenter, Randomized Controlled, Non-inferiority Trial (PERSIST Ⅲ Study)
Lead sponsor
ForQaly Medical (Shanghai) Co., Ltd
Phase
Not applicable
Overall status
Completed
Start date
September 10, 2024
Completion date
August 13, 2025
Enrollment
222 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterial disease (cad), high risk pci